• Lisinopril dihydrate ACE Inhibitor Workflows

  2026-09-03

  Build more reproducible ACE inhibition assays and disease models with a practical workflow for Lisinopril dihydrate. The guide combines solution-preparation controls, physiologic readouts, peptidase counter-screening, and troubleshooting for hypertension research, heart failure research, and renal studies.

• Eicosapentaenoic Acid (EPA): Mechanisms & Research

  2026-09-02

  Eicosapentaenoic Acid is an EPA omega-3 fatty acid used to study membrane lipid remodeling, lipid oxidation, inflammation, and vascular biology. The B3464 material is a research-grade EPA preparation with supplier-reported purity of approximately 98–99%, while its concentration-dependent assay effects should not be interpreted as clinical efficacy.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-09-02

  Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, tissue staining, flow cytometry, and compatible ELISA workflows. It should not be used as a universal secondary antibody, with non-goat primary antibodies, or in enzyme-substrate ELISA without separate validation.

• Bufalin Targets STK33 in Triple-Negative Breast Cancer

  2026-09-01

  The 2025 Advanced Science study identifies serine/threonine kinase 33 (STK33) as a direct binding partner and putative degradation target of Bufalin in triple-negative breast cancer. Through chemical-proteomic screening, biochemical validation, genetic perturbation, animal models, and patient-derived organoids, the authors connect STK33 loss to disruption of the CCAR1 tumor-promoting axis.

• AIBP-LRP2–HDL Control of Collateral Circulation

  2026-09-01

  Zhu et al. identify an AIBP–LRP2–HDL–miR-223 pathway that suppresses CXCR4 in capillary endothelial cells and limits collateral vessel growth after ischemia. The study proposes a two-phase model in which CXCR4-positive, stemlike endothelial cells first expand and then acquire arterial characteristics, offering a mechanistic framework for stage-aware revascularization research.

• Septin4, VHL, and HIF-1α in Cardiac Hypoxia

  2026-08-31

  The reference study identifies Septin4 as a previously unrecognized aggravator of hypoxia-induced cardiomyocyte injury. Its data support a mechanism in which Septin4 binds HIF-1α and promotes VHL-dependent ubiquitination and proteasomal degradation, linking a proapoptotic protein to impaired hypoxic adaptation.

• SMYD2 Inhibition Limits Cisplatin-Induced Renal Fibrosis

  2026-08-31

  The reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced chronic kidney disease, linking its activity to renal fibrosis, epithelial–mesenchymal transition, inflammation, and Smad3/STAT3 signaling. Inhibitors AZ505 and LLY507 reduced injury-associated molecular changes in an animal model, while AZ505 reproduced key effects in cultured tubular epithelial cells.

• T7 RNA Polymerase for In Vitro RNA Synthesis

  2026-08-30

  T7 RNA Polymerase is a recombinant enzyme expressed in E. coli that selectively transcribes RNA from DNA templates carrying a T7 promoter. Its defined template requirements support RNA synthesis from linearized plasmid templates and research workflows spanning antisense RNA, RNAi, and RNA vaccine production.

• GSK343: Selective EZH2 Inhibitor Guide

  2026-08-29

  GSK343 is a cell-permeable, SAM-competitive EZH2 inhibitor for mechanistic epigenetic cancer research. It suppresses EZH2-mediated H3K27me3 in biochemical and cellular assays, but high animal-model clearance makes it primarily an in vitro tool compound.

• ARL4C and EdU Assay Strategy for S-Phase Biology

  2026-08-28

  A translational framework for converting ARL4C-driven rheumatoid arthritis fibroblast-like synoviocyte biology into an interpretable S-phase, drug-response, and mechanistic validation workflow using the EdU Cell Proliferation Kit (TMB).

• O-GlcNAc–HUWE1–TfR1 Signaling in Preeclampsia

  2026-08-28

  This study identifies an O-GlcNAc–HUWE1–TfR1 regulatory axis that links trophoblast ferroptosis, iron uptake, and defective syncytialization in preeclampsia. Its combination of placental observations, O-GlcNAc modification proteomics, mechanistic validation, and mouse experiments provides a framework for testing how post-translational regulation of iron handling contributes to adverse pregnancy outcomes.

• Lipid Peroxidation Assay: From MDA to Ferroptosis

  2026-08-27

  The Lipid Peroxidation (MDA) Assay Kit enables sensitive MDA quantification while helping researchers distinguish oxidative damage from ferroptosis-specific mechanisms. This guide uses doxorubicin-induced liver injury research to build a more rigorous framework for assay selection, interpretation, and validation.

• Sulfo-Cy3 NHS Ester for Vascular Protein Labeling

  2026-08-27

  Learn how to use Sulfo-Cy3 NHS Ester as a water-compatible label for proteins, peptides, endothelial uptake assays, and quantum-dot conjugates. The workflow emphasizes controlled amine coupling, clean separation, quantitative fluorescence, and controls suited to the AIBP–LRP2–HDL–miR-223 vascular remodeling axis.

• JC-1 for Mitochondrial Membrane Potential Assays

  2026-08-26

  JC-1 is a cationic fluorescent probe for mitochondrial membrane potential that changes from green monomer fluorescence to red aggregate fluorescence as membrane potential increases. The 5,6-dichloro-2-[(E)-3-(5,6-dichloro-1,3-diethylbenzimidazol-3-ium-2-yl)prop-2-enylidene]-1,3-diethylbenzimidazole iodide signal supports mitochondrial dysfunction research and apoptosis detection, but it should be interpreted with viability and mechanistic controls.

• Sulfo-Cy3 NHS Ester for Vascular Protein Labeling

  2026-08-26

  Sulfo-Cy3 NHS Ester combines water compatibility with efficient primary-amine labeling, making it useful for soluble protein conjugation, uptake assays, and vascular cell studies. Its sulfonated structure is particularly valuable when conventional Cy3 workflows cause precipitation, denaturation, or dye-dye quenching.

8536 records 1/570 page Next 12345 下5页 Last page